Screener
BioCryst Pharmaceuticals BCRX Effective Income Tax Rate Reconciliation Tax Credits Research
Effective Income Tax Rate Reconciliation Tax Credits Research at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.
The source filing: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:03 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-012240
| Line item | Years Ended December 31, 2025 / Amount | Years Ended December 31, 2025 / Percent | Years Ended December 31, 2024 / Amount | Years Ended December 31, 2024 / Percent | Years Ended December 31, 2023 / Amount | Years Ended December 31, 2023 / Percent |
|---|---|---|---|---|---|---|
| Other | (880) | — | 30 | — | 46 | — |
| Other foreign jurisdictions | 704 | — | (228) | — | 464 | — |
| Tax credits | ||||||
| Research and development tax credits | (1,323) | — | (1,764) | 2% | (3,725) | 1% |
| Expiration of research and development tax credits | 3,574 | 1% | 2,514 | (3)% | 831 | — |
| Changes in valuation allowances | (52,454) | (20)% | 8,695 | (10)% | 42,139 | (19)% |
| Nontaxable or nondeductible items | ||||||
| Share-based payment awards | 4,837 | 2% | 2,780 | (3)% | 2,625 | (1)% |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research?
- BioCryst Pharmaceuticals (BCRX) reported effective income tax rate reconciliation tax credits research of $0 in Q4 2025.
- How has BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research changed year-over-year?
- BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research increased by 100.0% year-over-year, from -$0.01 to $0.
- What is the long-term trend for BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research?
- Over 2 years (2023 to 2025), BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research has grown at a -100.0% compound annual growth rate (CAGR), from -$0.01 to $0.
- What does effective income tax rate reconciliation tax credits research mean?
- Effective Income Tax Rate Reconciliation Tax Credits Research as reported by BioCryst Pharmaceuticals Inc.
Ask your AI about BioCryst Pharmaceuticals's effective income tax rate reconciliation tax credits research.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude